Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Barreiro

Showing results (21-30 of 220) with videos related to

Pageof 22
Sort By:
Expert Opinion on Pharmacotherapy|June 17, 2009
HIV protease inhibitors: recent clinical trials and recommendations on useJosé Vicente Fernández-Montero, Pablo Barreiro, Vicente Soriano
Seminars in Liver Disease|July 5, 2012
Management and treatment of chronic hepatitis C in HIV patientsPablo Barreiro, Eugenia Vispo, Pablo Labarga, et al.
AIDS Reviews|November 3, 2006
Reproductive options for HIV-serodiscordant couplesPablo Barreiro, Ann Duerr, Karen Beckerman, et al.
AIDS Reviews|May 26, 2012
Psychopharmacological treatments in HIV patients under antiretroviral therapyLucía Gallego, Pablo Barreiro, Juan J López-Ibor
AIDS Research and Human Retroviruses|July 2, 2005
Enfuvirtide is active against HIV type 1 group OEva Poveda, Pablo Barreiro, Berta Rodés, et al.
HIV Clinical Trials|March 15, 2005
Atazanavir: the advent of a new generation of more convenient protease inhibitorsPablo Barreiro, Ana Rendón, Sonia Rodríguez-Nóvoa, et al.
AIDS Reviews|January 31, 2003
Simplification of antiretroviral treatment--how to sustain success, reduce toxicity and ensure adherence avoiding PI usePablo Barreiro, Teresa García-Benayas, Vincent Soriano, et al.
HIV/AIDS (Auckland, N.Z.)|November 19, 2011
Long-term treatment of patients with HIV-1: the role of atazanavirMiguel Ángel Artacho, Pablo Barreiro, José Vicente Fernández-Montero
Expert Opinion on Biological Therapy|October 18, 2014
Gene therapy for HIV infectionCarmen de Mendoza, Pablo Barreiro, Laura Benitez, et al.
Human Reproduction (Oxford, England)|July 21, 2007
Is natural conception a valid option for HIV-serodiscordant couples?Pablo Barreiro, José Antonio Castilla, Pablo Labarga, et al.
Pageof 22

Showing results (21-30 of 220) with videos related to

Sort By:
Pageof 22
Expert Opinion on Pharmacotherapy|June 17, 2009
HIV protease inhibitors: recent clinical trials and recommendations on useJosé Vicente Fernández-Montero, Pablo Barreiro, Vicente Soriano
Seminars in Liver Disease|July 5, 2012
Management and treatment of chronic hepatitis C in HIV patientsPablo Barreiro, Eugenia Vispo, Pablo Labarga, et al.
AIDS Reviews|November 3, 2006
Reproductive options for HIV-serodiscordant couplesPablo Barreiro, Ann Duerr, Karen Beckerman, et al.
AIDS Reviews|May 26, 2012
Psychopharmacological treatments in HIV patients under antiretroviral therapyLucía Gallego, Pablo Barreiro, Juan J López-Ibor
AIDS Research and Human Retroviruses|July 2, 2005
Enfuvirtide is active against HIV type 1 group OEva Poveda, Pablo Barreiro, Berta Rodés, et al.
HIV Clinical Trials|March 15, 2005
Atazanavir: the advent of a new generation of more convenient protease inhibitorsPablo Barreiro, Ana Rendón, Sonia Rodríguez-Nóvoa, et al.
AIDS Reviews|January 31, 2003
Simplification of antiretroviral treatment--how to sustain success, reduce toxicity and ensure adherence avoiding PI usePablo Barreiro, Teresa García-Benayas, Vincent Soriano, et al.
HIV/AIDS (Auckland, N.Z.)|November 19, 2011
Long-term treatment of patients with HIV-1: the role of atazanavirMiguel Ángel Artacho, Pablo Barreiro, José Vicente Fernández-Montero
Expert Opinion on Biological Therapy|October 18, 2014
Gene therapy for HIV infectionCarmen de Mendoza, Pablo Barreiro, Laura Benitez, et al.
Human Reproduction (Oxford, England)|July 21, 2007
Is natural conception a valid option for HIV-serodiscordant couples?Pablo Barreiro, José Antonio Castilla, Pablo Labarga, et al.
Pageof 22